Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Woodruff

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Texas Heart Institute Journal|December 21, 2017
Hypertension and PregnancyCarol Lai, Stephanie A Coulter, Amy Woodruff
Clinical Neuropharmacology|September 25, 2010
Brugada-like electrocardiographic pattern induced by lamotrigine toxicityWilliam J Strimel, Amy Woodruff, Peter Cheung, et al.
Molecular Cancer Therapeutics|August 10, 2019
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human <i>PD-1xLAG-3</i>-Knockin MiceElena Burova, Aynur Hermann, Jie Dai, et al.
Molecular Cancer Therapeutics|March 8, 2017
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human <i>PD-1</i> Knock-In MiceElena Burova, Aynur Hermann, Janelle Waite, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Texas Heart Institute Journal|December 21, 2017
Hypertension and PregnancyCarol Lai, Stephanie A Coulter, Amy Woodruff
Clinical Neuropharmacology|September 25, 2010
Brugada-like electrocardiographic pattern induced by lamotrigine toxicityWilliam J Strimel, Amy Woodruff, Peter Cheung, et al.
Molecular Cancer Therapeutics|August 10, 2019
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human <i>PD-1xLAG-3</i>-Knockin MiceElena Burova, Aynur Hermann, Jie Dai, et al.
Molecular Cancer Therapeutics|March 8, 2017
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human <i>PD-1</i> Knock-In MiceElena Burova, Aynur Hermann, Janelle Waite, et al.
Pageof 1